Luis
Bujanda Fernández de Piérola
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (4)
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
2021
2018
-
Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14
International Journal of Cancer, Vol. 143, Núm. 11, pp. 2777-2786
2016
-
Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: Results of the Spanish follow-up multicenter study
Journal of Gastroenterology and Hepatology (Australia), Vol. 31, Núm. 5, pp. 953-958